Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

letter

. 2023 Feb 23;7(3):e847. doi: 10.1097/HS9.0000000000000847

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.

This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 2. — Significant prognostic factors for survival in CMML patients with SIAD. (A) OS of SIAD patients according to the autoimmune cytopenia status (20 patients with AI cytopenia, 27 without). (B) OS and (C) PFS of SIAD patients according to DNMT3A mutational status (4 DNMT3A^mut patients and 43 DNMT3A^wt). (D) PFS of SIAD patients according to ASXL1 mutational status (17 ASXL1^mut patients and 30 ASXL1^wt). (E) PFS of SIAD patients according to CUX1 mutational status (7 CUX1^mut patients and 40 CUX1^wt). For each panel, HR, and P value were computed with the multivariate Cox regression model. HR = hazard ratio; OS = overall survival; PFS = progression-free survival; SIAD = systemic inflammation and autoimmune disorders.